Retinal vein occlusion in child with rare mutations in genes for thrombophilia

被引:2
作者
Giancotta, C. [1 ]
Sanseviero, M. [1 ]
Talarico, V [1 ]
La Rosa, M. A. [2 ]
Galati, M. C. [3 ]
Raiola, G. [1 ]
Miniero, R. [1 ]
机构
[1] Pugliese Ciaccio Hosp, Dept Pediat, Catanzaro, Italy
[2] Univ Hosp G Martino, Unit Genet & Pediat Immunol, Messina, Italy
[3] Pugliese Ciaccio Hosp, Dept Pediat Oncohematol, Catanzaro, Italy
来源
CLINICA TERAPEUTICA | 2019年 / 170卷 / 03期
关键词
retinal vein occlusions; thrombophilia; bevacizumab; angiotesin converting enzyme; angiotensinogen; ENDOTHELIAL GROWTH-FACTOR; VENOUS OCCLUSION; MACULAR EDEMA; RISK-FACTORS; FACTOR-XII; IN-VIVO; RANIBIZUMAB; ROLES; VEGF;
D O I
10.7417/CT.2019.2126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Retinal vein occlusions (RVOs) are rare in the younger population. Hematological pro-thrombotic factors are thought to be important in a minority, amplifying an atherosclerotic anatomical predisposition. Case report. Anotherwise healthy 13-year-old girl presented two episodes of sudden decreased vision in few months. Ophthalmological exams pointed out post-thrombotic intra-retinal hemorrhage. All investigations were normal, thrombophilia screen showed factor XII deficiency and genetic mutations of methylenetetrahydrofolate reductase (MTHFR), angiotesin convertin enzyme (ACE) and angiotensinogen (AGT). Two intravitreal injection of bevacizumab was administered with improving visual acuity; subsequently the patient did not report further episodes. Discussion. In addition to traditional factors with procoagulant activity, factor XII deficiency plays an important role in thrombosis's mechanism. Its deficiency causes a marked prolongation of the activated partial thromboplastin time in the laboratory examination. Moreover also MTHFR, ACE and AGT could have been involved in this case, so it is important to evaluate these parameters in the differential diagnosis of RVOs.
引用
收藏
页码:E163 / E167
页数:5
相关论文
共 23 条
  • [1] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS
    AIELLO, LP
    PIERCE, EA
    FOLEY, ED
    TAKAGI, H
    CHEN, H
    RIDDLE, L
    FERRARA, N
    KING, GL
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10457 - 10461
  • [2] Central retinal venous occlusion in an otherwise-healthy child
    Al-Dhibi, Hasan
    Al-Saati, Anoud
    Khan, Arif O.
    [J]. JOURNAL OF AAPOS, 2007, 11 (02): : 189 - 191
  • [3] [Anonymous], COCHRANE DATABASE SY
  • [4] Bowling B., 2015, KANSKIS CLIN OPHATAL, P538
  • [5] Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator
    Campochiaro, Peter A.
    Hafiz, Gulnar
    Shah, Syed Mahmood
    Nguyen, Quan Dong
    Ying, Howard
    Do, Diana V.
    Quinlan, Edward
    Zimmer-Galler, Ingrid
    Haller, Julia A.
    Solomon, Sharon D.
    Sung, Jennifer U.
    Hadi, Yasmin
    Janjua, Kashif A.
    Jawed, Nida
    Choy, David F.
    Arron, Joseph R.
    [J]. MOLECULAR THERAPY, 2008, 16 (04) : 791 - 799
  • [6] Cruciani F, 2003, Clin Ter, V154, P299
  • [7] Dhar-Munshi S, 1999, ARCH OPHTHALMOL-CHIC, V117, P971
  • [8] Association of polymorphisms in the AGT gene(M235T, T174M) with ischemic stroke in the Chinese population
    Gao, Tao
    Huang, Lina
    Fu, Qizhi
    Bai, Yongjie
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (03) : 681 - 686
  • [9] Managing retinal vein occlusion
    Kiire, Christine A.
    Chong, N. Victor
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344 : 37 - 43
  • [10] Multiple thrombophilic risk markers in patients <65 years of age with retinal vein occlusion
    Kuhli-Hattenbach, C.
    Hellstern, P.
    Miesbach, W.
    Kohnen, T.
    Hattenbach, L. -O.
    [J]. OPHTHALMOLOGE, 2017, 114 (12): : 1149 - 1154